Publications by Thomas G. von Lueder
47 publications found
Original articles
Cardiovascular phenotype of long-term anabolic-androgenic steroid abusers compared with strength-trained athletes
Scand J Med Sci Sports, 32 (8), 1170-1181
DOI 10.1111/sms.14172, PubMed 35460300
Hypertension and heart failure with preserved ejection fraction: position paper by the European Society of Hypertension
J Hypertens, 39 (8), 1522-1545
DOI 10.1097/HJH.0000000000002910, PubMed 34102660
Case report: a patient with thyroid storm, refractory cardiogenic shock, and cardiac arrest treated with Lugol's iodine solution and veno-arterial extra corporal membrane oxygenation support
Eur Heart J Case Rep, 5 (2), ytab017
DOI 10.1093/ehjcr/ytab017, PubMed 33569532
Cardiac Dimensions and Function Are Not Altered among Females with the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Healthcare (Basel), 8 (4)
DOI 10.3390/healthcare8040406, PubMed 33081294
Impact of Renal Impairment on Beta-Blocker Efficacy in Patients With Heart Failure
J Am Coll Cardiol, 74 (23), 2893-2904
DOI 10.1016/j.jacc.2019.09.059, PubMed 31806133
Left ventricular ejection fraction and adjudicated, cause-specific hospitalizations after myocardial infarction complicated by heart failure or left ventricular dysfunction
Am Heart J, 215, 83-90
DOI 10.1016/j.ahj.2019.06.004, PubMed 31291604
All-Cause Mortality and Cardiovascular Outcomes With Non-Vitamin K Oral Anticoagulants Versus Warfarin in Patients With Heart Failure in the Food and Drug Administration Adverse Event Reporting System
Am J Ther, 26 (6), e671-e678
DOI 10.1097/MJT.0000000000000883, PubMed 31145139
Angiotensin receptor neprilysin inhibition provides superior cardioprotection compared to angiotensin converting enzyme inhibition after experimental myocardial infarction
Int J Cardiol, 258, 192-198
DOI 10.1016/j.ijcard.2018.01.077, PubMed 29544929
Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials
Eur Heart J, 39 (1), 26-35
DOI 10.1093/eurheartj/ehx564, PubMed 29040525
Heart rate prediction of outcome in heart failure following myocardial infarction depend on heart rhythm status an analysis from the high-risk myocardial infarction database initiative
Int J Cardiol, 249, 274-281
DOI 10.1016/j.ijcard.2017.09.182, PubMed 28964557
Heart Rate and Rhythm and the Benefit of Beta-Blockers in Patients With Heart Failure
J Am Coll Cardiol, 69 (24), 2885-2896
DOI 10.1016/j.jacc.2017.04.001, PubMed 28467883
Left ventricular biomechanics in professional football players
Scand J Med Sci Sports, 28 (1), 187-195
DOI 10.1111/sms.12893, PubMed 28378431
Neurohormonal Blockade in Heart Failure
Card Fail Rev, 3 (1), 19-24
DOI 10.15420/cfr.2016:22:2, PubMed 28785471
Effect of age and sex on efficacy and tolerability of β blockers in patients with heart failure with reduced ejection fraction: individual patient data meta-analysis
BMJ, 353, i1855
DOI 10.1136/bmj.i1855, PubMed 27098105
Serum uric acid is associated with mortality and heart failure hospitalizations in patients with complicated myocardial infarction: findings from the High-Risk Myocardial Infarction Database Initiative
Eur J Heart Fail, 17 (11), 1144-51
DOI 10.1002/ejhf.419, PubMed 26424212
Angiotensin receptor neprilysin inhibitor LCZ696 attenuates cardiac remodeling and dysfunction after myocardial infarction by reducing cardiac fibrosis and hypertrophy
Circ Heart Fail, 8 (1), 71-8
DOI 10.1161/CIRCHEARTFAILURE.114.001785, PubMed 25362207
Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis
Lancet, 384 (9961), 2235-43
DOI 10.1016/S0140-6736(14)61373-8, PubMed 25193873
Comorbidities and polypharmacy
Heart Fail Clin, 10 (2), 367-72
DOI 10.1016/j.hfc.2013.12.001, PubMed 24656112
Renin-angiotensin blockade combined with natriuretic peptide system augmentation: novel therapeutic concepts to combat heart failure
Circ Heart Fail, 6 (3), 594-605
DOI 10.1161/CIRCHEARTFAILURE.112.000289, PubMed 23694773
CCN2/CTGF attenuates myocardial hypertrophy and cardiac dysfunction upon chronic pressure-overload
Int J Cardiol, 168 (3), 2049-56
DOI 10.1016/j.ijcard.2013.01.165, PubMed 23452880
Cardiomyocyte-restricted inhibition of G protein-coupled receptor kinase-3 attenuates cardiac dysfunction after chronic pressure overload
Am J Physiol Heart Circ Physiol, 303 (1), H66-74
DOI 10.1152/ajpheart.00724.2011, PubMed 22542621
Amyotrophic lateral sclerosis (ALS), a novel rare cause of elevated plasma troponin T levels
Clin Lab, 57 (7-8), 615-8
PubMed 21888026
Mechanisms of novel cardioprotective functions of CCN2/CTGF in myocardial ischemia-reperfusion injury
Am J Physiol Heart Circ Physiol, 300 (4), H1291-302
DOI 10.1152/ajpheart.00604.2010, PubMed 21186275
Separate mechanisms cause anemia in ischemic vs. nonischemic murine heart failure
Am J Physiol Regul Integr Comp Physiol, 298 (3), R808-14
DOI 10.1152/ajpregu.00250.2009, PubMed 20032264
Cardiac-restricted expression of the carboxyl-terminal fragment of GRK3 Uncovers Distinct Functions of GRK3 in regulation of cardiac contractility and growth: GRK3 controls cardiac alpha1-adrenergic receptor responsiveness
J Biol Chem, 283 (16), 10601-10
DOI 10.1074/jbc.M708912200, PubMed 18165681
Induction of pulmonary connective tissue growth factor in heart failure is associated with pulmonary parenchymal and vascular remodeling
Cardiovasc Res, 74 (2), 323-33
DOI 10.1016/j.cardiores.2006.12.010, PubMed 17254558
Induction of myocardial connective tissue growth factor in pacing-induced heart failure in pigs
Acta Physiol Scand, 184 (1), 27-36
DOI 10.1111/j.1365-201X.2005.01416.x, PubMed 15847641
Mechanisms of elevated plasma endothelin-1 in CHF: congestion increases pulmonary synthesis and secretion of endothelin-1
Cardiovasc Res, 63 (1), 41-50
DOI 10.1016/j.cardiores.2004.03.016, PubMed 15194460
Review articles
Medical Therapies for Heart Failure With Preserved Ejection Fraction
Hypertension, 75 (1), 23-32
DOI 10.1161/HYPERTENSIONAHA.119.14057, PubMed 31786973
Potential mechanisms underlying the cardiovascular benefits of sodium glucose cotransporter 2 inhibitors: a systematic review of data from preclinical studies
Cardiovasc Res, 115 (2), 266-276
DOI 10.1093/cvr/cvy295, PubMed 30475996
Relationship between left ventricular ejection fraction and mortality after myocardial infarction complicated by heart failure or left ventricular dysfunction
Int J Cardiol, 272, 260-266
DOI 10.1016/j.ijcard.2018.07.137, PubMed 30144995
Comorbidities in Heart Failure: Are There Gender Differences?
Curr Heart Fail Rep, 13 (1), 1-12
DOI 10.1007/s11897-016-0280-1, PubMed 26829930
New medical therapies for heart failure
Nat Rev Cardiol, 12 (12), 730-40
DOI 10.1038/nrcardio.2015.137, PubMed 26416006
Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction
J Am Coll Cardiol, 64 (21), 2281-93
DOI 10.1016/j.jacc.2014.08.036, PubMed 25456761
Current role of neprilysin inhibitors in hypertension and heart failure
Pharmacol Ther, 144 (1), 41-9
DOI 10.1016/j.pharmthera.2014.05.002, PubMed 24836726
Diuretic use in heart failure and outcomes
Clin Pharmacol Ther, 94 (4), 490-8
DOI 10.1038/clpt.2013.140, PubMed 23852396
RAAS inhibitors and cardiovascular protection in large scale trials
Cardiovasc Drugs Ther, 27 (2), 171-9
DOI 10.1007/s10557-012-6424-y, PubMed 23224653
Current modalities for invasive and non-invasive monitoring of volume status in heart failure
Heart, 98 (13), 967-73
DOI 10.1136/heartjnl-2011-301330, PubMed 22572046
Other articles
Angiotensin receptor neprilysin inhibition for the treatment of hypertension: the neglected child in cardiovascular pharmacotherapy
Eur Heart J Cardiovasc Pharmacother, 5 (2), 122-123
DOI 10.1093/ehjcvp/pvz005, PubMed 30698668
The burden of heart failure in the general population: a clearer and more concerning picture
J Thorac Dis, 10 (Suppl 17), S1934-S1937
DOI 10.21037/jtd.2018.04.153, PubMed 30023084
In memoriam Henry Krum, 1958-2015
Cardiology, 134 (2), 107-8
DOI 10.1159/000444294, PubMed 26950607
The Prognostic Role of Serum Uric Acid (SUA) in Coronary Artery Disease: PerSUAsive Data Plea for a Large Morbidity-Mortality Trial
Cardiology, 134 (3), 357-9
DOI 10.1159/000444744, PubMed 27007801
Digoxin withdrawal worsens clinical status in stable patients with heart failure receiving optimal contemporaneous therapy--a randomized controlled trial
J Card Fail, 21 (9), 779-81
DOI 10.1016/j.cardfail.2015.07.003, PubMed 26169443
Qualifying the use of common cardiovascular drugs in cardiology
Circ J, 79 (3), 517-8
DOI 10.1253/circj.CJ-15-0088, PubMed 25746532
Combined angiotensin receptor blockade and neprilysin inhibition attenuates angiotensin-II mediated renal cellular collagen synthesis
Int J Cardiol, 186, 104-5
DOI 10.1016/j.ijcard.2015.03.116, PubMed 25828104
Books
Molecular mechanisms of myocardial hypertrophy and heart failure: experimental studies on cardiac G protein-coupled receptor signaling with emphasis on endothelin-1
In Hjerteforum, Supplement, Norsk cardiologisk selskap, Oslo, 22(2009)2b, 1 b. (flere pag.)
BIBSYS 100067271
Theses
Molecular mechanisms of myocardial hypertrophy and heart failure: experimental studies on cardiac G protein-coupled receptor signaling with emphasis on endothelin-1
In Series of dissertations submitted to the Faculty of Medicine, University of Oslo, Unipub, Oslo, no. 810, 1 b. (flere pag.)
BIBSYS 093346751, ISBN 978-82-8072-799-2